Cell‐Free Extracts from Human Fat Tissue with a Hyaluronan‐Based Hydrogel Attenuate Inflammation in a Spinal Cord Injury Model through M2 Microglia/Microphage Polarization
Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support t...
Uloženo v:
| Vydáno v: | Small (Weinheim an der Bergstrasse, Germany) Ročník 18; číslo 17; s. e2107838 - n/a |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Germany
Wiley Subscription Services, Inc
01.04.2022
|
| Témata: | |
| ISSN: | 1613-6810, 1613-6829, 1613-6829 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro‐ and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti‐inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg‐1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective.
Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice, which demonstrate an impressing recovery. |
|---|---|
| AbstractList | Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro‐ and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti‐inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg‐1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective. Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell-free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro- and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti-inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg-1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective.Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell-free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro- and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti-inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg-1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective. Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and secondary inflammation. The current promising strategy for SCI is the combination of bioactive materials and cytokines. Bioactive materials support the injured spinal cord, stabilize the morphology, and avoid excessive inflammatory responses. Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice. The composite not only inhibits death of neuro‐ and vascular cells and leads to the preservation of neural and vascular structure, but also modulates the inflammatory phenotype of macrophages in the locally injured region. Specifically, FE promotes the polarization of macrophages from an inflammatory M1 phenotype to an anti‐inflammatory M2 phenotype. During the screening of the involved pathways, it is corroborated that activation of the STAT6/Arg‐1 signaling pathway is involved in macrophage M2 polarization. In summary, FE is a promising treatment for SCI, as it is easy to obtain, nonimmunogenic, and effective. Fat extract (FE) is a cell‐free liquid component containing a variety of cytokines extracted from human fat tissue using mechanical methods. In this research, a biocompatible HAMC (hyaluronan and methylcellulose) loaded with FE is used to treat a model of spinal cord contusion in mice, which demonstrate an impressing recovery. |
| Author | Xu, Shun Zhang, Wen‐Jie Ma, Xiao‐Sheng Zhang, Yu‐Xuan Yu, Zi‐You Zou, Fei Xia, Xin‐Lei Jiang, Jian‐Yuan Xu, Guang‐Yu Song, Jian |
| Author_xml | – sequence: 1 givenname: Guang‐Yu surname: Xu fullname: Xu, Guang‐Yu organization: Fudan University – sequence: 2 givenname: Shun surname: Xu fullname: Xu, Shun organization: Fudan University – sequence: 3 givenname: Yu‐Xuan surname: Zhang fullname: Zhang, Yu‐Xuan organization: Fudan University – sequence: 4 givenname: Zi‐You surname: Yu fullname: Yu, Zi‐You organization: Shanghai Key Laboratory of Tissue Engineering – sequence: 5 givenname: Fei surname: Zou fullname: Zou, Fei organization: Fudan University – sequence: 6 givenname: Xiao‐Sheng surname: Ma fullname: Ma, Xiao‐Sheng organization: Fudan University – sequence: 7 givenname: Xin‐Lei surname: Xia fullname: Xia, Xin‐Lei organization: Fudan University – sequence: 8 givenname: Wen‐Jie surname: Zhang fullname: Zhang, Wen‐Jie organization: Shanghai Key Laboratory of Tissue Engineering – sequence: 9 givenname: Jian‐Yuan surname: Jiang fullname: Jiang, Jian‐Yuan email: jianyuanjiang@sina.com organization: Fudan University – sequence: 10 givenname: Jian orcidid: 0000-0001-5850-025X surname: Song fullname: Song, Jian email: jsong16@fudan.edu.cn organization: Fudan University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35333441$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkctuEzEUhkeoiF5gyxJZYsMmqW9zW5aoaSolAqllPToz9iSOPHbwRSWseIS-Ce_Ek-AkJUiVECsf2d93rHP-8-zEWCOz7C3BY4IxvfSD1mOKKcFlxaoX2RkpCBsVFa1PjjXBp9m592uMGaG8fJWdspwxxjk5y35OpNa_fjxOnZTo-ltw0AWPemcHNIsDGDSFgO6V91GiBxVWCNBsCzo6a8Ak7yN4KdKVcHYpNboKQZoIQaJb02sYBgjKGqRM8u42yoBGE-tEel1Ht0ULK5IUVs7G5QotKFqoLjXSCi731WYFS4k-Ww1Ofd-3ep297EF7-ebpvMi-TK_vJ7PR_NPN7eRqPupYyaoRFa1Mo9KqxV1eFTUvOM0F5IKDpC3jkvaY533Z47pldV4JQVosqr6juMMUC3aRfTj03Tj7NUofmkH5Lu0KjLTRN7TgHBNclyyh75-haxtdGnVH5TmnJCWVqHdPVGwHKZqNUwO4bfMnigSMD0Ca23sn-yNCcLPLutll3RyzTgJ_JnQq7JeUUlT631p90B6Ultv_fNLcLebzv-5vjhjByA |
| CitedBy_id | crossref_primary_10_1002_adfm_202407958 crossref_primary_10_3389_fimmu_2022_993168 crossref_primary_10_1002_adfm_202213342 crossref_primary_10_1016_j_ijbiomac_2024_134591 crossref_primary_10_1080_10495398_2024_2442351 crossref_primary_10_3389_fbioe_2023_1111882 crossref_primary_10_1007_s11626_023_00846_3 crossref_primary_10_1016_j_matdes_2024_113356 crossref_primary_10_1002_kjm2_70041 crossref_primary_10_1007_s40883_025_00462_5 crossref_primary_10_1155_2023_3626091 crossref_primary_10_1021_acsami_5c09766 crossref_primary_10_1002_advs_202402114 crossref_primary_10_1186_s12967_024_05492_1 crossref_primary_10_1016_j_ijbiomac_2023_126854 crossref_primary_10_1016_j_ijbiomac_2024_138384 crossref_primary_10_1038_s41598_025_16621_1 crossref_primary_10_1002_adhm_202402129 crossref_primary_10_1016_j_intimp_2025_115086 crossref_primary_10_1186_s12951_025_03098_3 crossref_primary_10_1186_s12951_023_01996_y crossref_primary_10_31083_j_jin2309171 crossref_primary_10_1016_j_eng_2024_12_027 crossref_primary_10_1016_j_heliyon_2023_e19933 crossref_primary_10_1038_s41598_024_72593_8 crossref_primary_10_3390_biomedicines13061344 crossref_primary_10_1002_adfm_202508435 crossref_primary_10_1096_fj_202502341R crossref_primary_10_3389_fbioe_2024_1373419 crossref_primary_10_1038_s41392_025_02124_y crossref_primary_10_1177_20417314221143059 crossref_primary_10_1186_s40824_023_00339_0 crossref_primary_10_3389_fbioe_2023_1216878 crossref_primary_10_1016_j_intimp_2025_115330 crossref_primary_10_1016_j_bbrep_2025_102063 crossref_primary_10_1002_smll_202305659 crossref_primary_10_1080_17520363_2024_2366149 crossref_primary_10_3390_gels9110907 crossref_primary_10_1002_adhm_202304300 crossref_primary_10_1186_s12951_024_03037_8 crossref_primary_10_1016_j_intimp_2022_109120 crossref_primary_10_1002_smll_202310194 crossref_primary_10_1016_j_ijbiomac_2024_131520 crossref_primary_10_1016_j_jconrel_2025_01_007 crossref_primary_10_1007_s12035_025_04793_w crossref_primary_10_1093_procel_pwad003 crossref_primary_10_3390_pharmaceutics15051334 crossref_primary_10_1002_adma_202413957 crossref_primary_10_1002_smll_202304318 crossref_primary_10_1002_adfm_202307711 crossref_primary_10_1063_5_0275183 crossref_primary_10_1111_cns_14550 crossref_primary_10_1111_cns_70163 crossref_primary_10_1016_j_ijbiomac_2025_146115 |
| Cites_doi | 10.1001/jama.2015.6250 10.1016/j.biomaterials.2005.11.015 10.1016/j.biomaterials.2020.119978 10.1016/j.expneurol.2013.01.026 10.1016/j.biomaterials.2018.08.037 10.1002/glia.20215 10.1089/neu.2007.0426 10.1155/2019/6146942 10.1089/neu.2009.1177 10.1016/j.biomaterials.2018.03.044 10.1016/j.addr.2017.05.010 10.1073/pnas.1820276116 10.1097/00007632-200112151-00002 10.1016/S0140-6736(02)07603-1 10.1016/j.tice.2016.05.008 10.1016/j.cellimm.2020.104047 10.1186/s12974-018-1193-6 10.1089/wound.2017.0775 10.1016/j.jconrel.2009.05.025 10.1021/acsami.8b05293 10.1089/neu.2006.23.635 10.1016/j.actbio.2019.11.012 10.1111/j.1471-4159.2011.07257.x 10.1038/nrneurol.2010.73 10.1088/1741-2560/8/4/046033 10.3389/fcell.2021.570451 10.1155/2015/948040 10.1089/ten.tea.2007.0349 10.1016/j.biomaterials.2012.03.022 10.1093/brain/awy128 10.3171/spi.2001.95.2.0221 10.2478/s11658-013-0101-4 10.1016/j.biomaterials.2017.06.019 10.1007/s10571-015-0182-x 10.1177/0363546519848678 10.1007/s13311-013-0254-x 10.1088/1741-2552/aaa55c 10.1158/1078-0432.CCR-09-1015 10.1016/S0955-0674(00)00199-X 10.1097/PRS.0b013e31829fe1b0 10.3389/fimmu.2020.02135 10.1016/j.pneurobio.2010.11.002 10.1002/adma.201501558 10.1016/S1474-4422(18)30415-0 10.1038/srep34842 10.1172/jci.insight.131355 10.1039/C7BM00485K 10.1021/cn200030w 10.4049/jimmunol.180.6.4235 10.1016/j.pneurobio.2015.09.003 10.1152/physrev.00017.2017 10.1016/j.brainresbull.2019.03.005 10.1186/s13287-016-0356-6 10.1186/s12974-020-1726-7 10.1016/j.brainres.2014.12.045 10.1016/j.pharmthera.2013.01.004 10.1038/nature04478 10.1089/ten.teb.2011.0488 10.1016/j.biopha.2017.04.126 10.1016/j.jconrel.2015.08.060 10.1111/cns.13187 10.3390/cells9092113 10.1016/S0079-6123(06)61027-3 |
| ContentType | Journal Article |
| Copyright | 2022 Wiley‐VCH GmbH 2022 Wiley-VCH GmbH. |
| Copyright_xml | – notice: 2022 Wiley‐VCH GmbH – notice: 2022 Wiley-VCH GmbH. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7SR 7U5 8BQ 8FD JG9 L7M 7X8 |
| DOI | 10.1002/smll.202107838 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Engineered Materials Abstracts Solid State and Superconductivity Abstracts METADEX Technology Research Database Materials Research Database Advanced Technologies Database with Aerospace MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Materials Research Database Engineered Materials Abstracts Solid State and Superconductivity Abstracts Technology Research Database Advanced Technologies Database with Aerospace METADEX MEDLINE - Academic |
| DatabaseTitleList | Materials Research Database CrossRef MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering |
| EISSN | 1613-6829 |
| EndPage | n/a |
| ExternalDocumentID | 35333441 10_1002_smll_202107838 SMLL202107838 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: 82072488; 82102620 – fundername: Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research funderid: 2019CXJQ01 – fundername: Shanghai Sailing Program funderid: 20YF1429900; 20YF1438100 |
| GroupedDBID | --- 05W 0R~ 123 1L6 1OC 33P 3SF 3WU 4.4 50Y 52U 53G 5VS 66C 8-0 8-1 8UM A00 AAESR AAEVG AAHHS AAHQN AAIHA AAMNL AANLZ AAONW AAXRX AAYCA AAZKR ABCUV ABIJN ABJNI ABLJU ABRTZ ACAHQ ACCFJ ACCZN ACFBH ACGFS ACIWK ACPOU ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AITYG AIURR AIWBW AJBDE AJXKR ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZVAB BFHJK BHBCM BMNLL BMXJE BNHUX BOGZA BRXPI CS3 DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EMOBN F5P G-S GNP HBH HGLYW HHY HHZ HZ~ IX1 KQQ LATKE LAW LEEKS LITHE LOXES LUTES LYRES MEWTI MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM MY~ O66 O9- OIG P2P P2W P4E QRW R.K RIWAO RNS ROL RWI RX1 RYL SUPJJ SV3 V2E W99 WBKPD WFSAM WIH WIK WJL WOHZO WXSBR WYISQ WYJ XV2 Y6R ZZTAW ~S- 31~ AAMMB AANHP AASGY AAYXX ACBWZ ACRPL ACYXJ ADNMO AEFGJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY ASPBG AVWKF AZFZN BDRZF CITATION EJD FEDTE GODZA HVGLF LH4 AAYOK CGR CUY CVF ECM EIF NPM 7SR 7U5 8BQ 8FD JG9 L7M 7X8 |
| ID | FETCH-LOGICAL-c3738-2dbe24728b0c586946425da5d4ae2b34e2f045f7f09b3958dd1b0d8fc20c020d3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 68 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000772904400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1613-6810 1613-6829 |
| IngestDate | Fri Sep 05 12:31:29 EDT 2025 Fri Jul 25 12:21:13 EDT 2025 Wed Feb 19 02:25:54 EST 2025 Sat Nov 29 04:10:40 EST 2025 Tue Nov 18 22:00:49 EST 2025 Wed Jan 22 16:26:11 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 17 |
| Keywords | STAT6 M2 polarization spinal cord injuries fat extract |
| Language | English |
| License | 2022 Wiley-VCH GmbH. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3738-2dbe24728b0c586946425da5d4ae2b34e2f045f7f09b3958dd1b0d8fc20c020d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-5850-025X |
| PMID | 35333441 |
| PQID | 2655421100 |
| PQPubID | 1046358 |
| PageCount | 14 |
| ParticipantIDs | proquest_miscellaneous_2644010973 proquest_journals_2655421100 pubmed_primary_35333441 crossref_primary_10_1002_smll_202107838 crossref_citationtrail_10_1002_smll_202107838 wiley_primary_10_1002_smll_202107838_SMLL202107838 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-04-01 |
| PublicationDateYYYYMMDD | 2022-04-01 |
| PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany – name: Weinheim |
| PublicationTitle | Small (Weinheim an der Bergstrasse, Germany) |
| PublicationTitleAlternate | Small |
| PublicationYear | 2022 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2015; 35 2017; 5 2019; 2019 2010; 16 2017; 2 2011; 117 2018; 168 2002; 359 2020; 17 2016; 144 2019; 18 2012; 18 2020; 11 2020; 245 2018; 7 2013; 18 2018; 9 2006; 23 2006; 27 2020; 9 2008; 25 2019; 116 2015; 219 2011; 28 2017; 122 2001; 13 2016; 48 2001; 95 2010; 6 2009; 15 2014; 11 2021; 9 2018; 141 2019; 4 2011; 2 2018; 183 2007; 161 2015; 1619 2019; 148 2005; 438 2020; 349 2001; 26 2020; 101 2012; 33 2011; 8 2008; 180 2016; 6 2016; 7 2017; 91 2015; 27 2015; 313 2011; 93 2013; 138 2019; 47 2015; 2015 2005; 52 2020; 26 2017; 140 2014; 260 2009; 140 2013; 132 2020; 21 2018; 98 2018; 10 2018; 15 e_1_2_9_31_1 e_1_2_9_52_1 e_1_2_9_50_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_56_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_54_1 Rochette L. (e_1_2_9_17_1) 2020; 21 Yu Z. (e_1_2_9_14_1) 2018; 9 e_1_2_9_39_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_58_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_64_1 e_1_2_9_20_1 e_1_2_9_62_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_24_1 e_1_2_9_43_1 Liu T. (e_1_2_9_53_1) 2017; 2 e_1_2_9_66_1 e_1_2_9_8_1 e_1_2_9_6_1 e_1_2_9_4_1 e_1_2_9_60_1 e_1_2_9_2_1 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_30_1 e_1_2_9_51_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_19_1 Yamazaki K. (e_1_2_9_7_1) 2020; 21 e_1_2_9_42_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_61_1 e_1_2_9_21_1 e_1_2_9_46_1 e_1_2_9_67_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_65_1 e_1_2_9_5_1 e_1_2_9_3_1 e_1_2_9_1_1 e_1_2_9_9_1 e_1_2_9_25_1 e_1_2_9_27_1 e_1_2_9_48_1 e_1_2_9_29_1 |
| References_xml | – volume: 25 start-page: 350 year: 2008 publication-title: J Neurotrauma – volume: 148 start-page: 46 year: 2019 publication-title: Brain Res. Bull. – volume: 13 start-page: 211 year: 2001 publication-title: Curr. Opin. Cell Biol. – volume: 18 start-page: 56 year: 2019 publication-title: Lancet Neurol. – volume: 15 start-page: 595 year: 2009 publication-title: Tissue Eng Part A – volume: 219 start-page: 141 year: 2015 publication-title: J. Controlled Release – volume: 2019 year: 2019 publication-title: Oxid. Med. Cell. Longev – volume: 15 year: 2018 publication-title: J. Neural Eng. – volume: 116 year: 2019 publication-title: Proc. Natl. Acad. Sci. USA – volume: 140 start-page: 218 year: 2009 publication-title: J. Controlled Release – volume: 7 start-page: 299 year: 2018 publication-title: Adv. Wound Care (New Rochelle) – volume: 93 start-page: 204 year: 2011 publication-title: Prog. Neurobiol. – volume: 140 start-page: 103 year: 2017 publication-title: Biomater. – volume: 28 start-page: 1611 year: 2011 publication-title: J. Neurotrauma – volume: 132 start-page: 1017 year: 2013 publication-title: Plast. Reconstr. Surg. – volume: 260 start-page: 44 year: 2014 publication-title: Exp Neurol – volume: 9 year: 2018 publication-title: Stem Cell Res. Ther. – volume: 98 start-page: 881 year: 2018 publication-title: Physiol. Rev. – volume: 23 start-page: 635 year: 2006 publication-title: J Neurotrauma – volume: 11 start-page: 636 year: 2014 publication-title: Neurotherapeutics – volume: 17 start-page: 47 year: 2020 publication-title: J. Neuroinflammation – volume: 122 start-page: 74 year: 2017 publication-title: Adv. Drug Deliv. Rev. – volume: 5 start-page: 2480 year: 2017 publication-title: Biomater. Sci. – volume: 9 year: 2021 publication-title: Front. Cell Dev. Biol. – volume: 26 start-page: 189 year: 2020 publication-title: CNS Neurosci. Ther. – volume: 27 start-page: 3717 year: 2015 publication-title: Adv. Mater. – volume: 138 start-page: 155 year: 2013 publication-title: Pharmacol. Ther. – volume: 21 year: 2020 publication-title: Int. J. Mol. Sci. – volume: 161 start-page: 385 year: 2007 publication-title: Prog. Brain Res. – volume: 144 start-page: 188 year: 2016 publication-title: Prog. Neurobiol. – volume: 35 start-page: 881 year: 2015 publication-title: Cell. Mol. Neurobiol. – volume: 27 start-page: 2370 year: 2006 publication-title: Biomater. – volume: 101 start-page: 357 year: 2020 publication-title: Acta. Biomater. – volume: 349 year: 2020 publication-title: Cell. Immunol. – volume: 11 start-page: 2135 year: 2020 publication-title: Front. Immunol. – volume: 117 start-page: 892 year: 2011 publication-title: J. Neurochem. – volume: 359 start-page: 417 year: 2002 publication-title: Lancet – volume: 313 start-page: 2236 year: 2015 publication-title: JAMA, J. Am. Med. Assoc. – volume: 18 start-page: 479 year: 2013 publication-title: Cell. Mol. Biol. Lett. – volume: 8 year: 2011 publication-title: J. Neural Eng. – volume: 48 start-page: 328 year: 2016 publication-title: Tissue Cell – volume: 4 year: 2019 publication-title: JCI Insight – volume: 7 start-page: 102 year: 2016 publication-title: Stem Cell Res. Ther. – volume: 180 start-page: 4235 year: 2008 publication-title: J. Immunol. – volume: 141 start-page: 1946 year: 2018 publication-title: Brain – volume: 2015 year: 2015 publication-title: Stem Cells Int. – volume: 168 start-page: 24 year: 2018 publication-title: Biomaterials – volume: 2 year: 2017 publication-title: Signal Transduct. Target Ther. – volume: 26 start-page: S2 year: 2001 publication-title: Spine (Phila Pa 1976) – volume: 245 year: 2020 publication-title: Biomater. – volume: 91 start-page: 693 year: 2017 publication-title: Biomed. Pharmacother. – volume: 438 start-page: 932 year: 2005 publication-title: Nature – volume: 95 start-page: 221 year: 2001 publication-title: J. Neurosurg. – volume: 15 start-page: 150 year: 2018 publication-title: J. Neuroinflammation – volume: 2 start-page: 336 year: 2011 publication-title: ACS Chem. Neurosci. – volume: 183 start-page: 114 year: 2018 publication-title: Biomater. – volume: 18 start-page: 101 year: 2012 publication-title: Tissue Eng. Part B Rev. – volume: 9 start-page: 2113 year: 2020 publication-title: Cells – volume: 47 start-page: 1722 year: 2019 publication-title: Am. J. Sports Med. – volume: 1619 start-page: 1 year: 2015 publication-title: Brain Res. – volume: 52 start-page: 16 year: 2005 publication-title: Glia – volume: 16 start-page: 784 year: 2010 publication-title: Clin. Cancer Res. – volume: 6 year: 2016 publication-title: Sci. Rep. – volume: 33 start-page: 4555 year: 2012 publication-title: Biomater. – volume: 10 year: 2018 publication-title: ACS Appl. Mater. Interfaces – volume: 6 start-page: 363 year: 2010 publication-title: Nat. Rev. Neurol. – ident: e_1_2_9_1_1 doi: 10.1001/jama.2015.6250 – ident: e_1_2_9_21_1 doi: 10.1016/j.biomaterials.2005.11.015 – volume: 9 year: 2018 ident: e_1_2_9_14_1 publication-title: Stem Cell Res. Ther. – ident: e_1_2_9_67_1 doi: 10.1016/j.biomaterials.2020.119978 – ident: e_1_2_9_45_1 doi: 10.1016/j.expneurol.2013.01.026 – volume: 2 year: 2017 ident: e_1_2_9_53_1 publication-title: Signal Transduct. Target Ther. – ident: e_1_2_9_32_1 doi: 10.1016/j.biomaterials.2018.08.037 – ident: e_1_2_9_43_1 doi: 10.1002/glia.20215 – ident: e_1_2_9_62_1 doi: 10.1089/neu.2007.0426 – ident: e_1_2_9_29_1 doi: 10.1155/2019/6146942 – ident: e_1_2_9_26_1 doi: 10.1089/neu.2009.1177 – ident: e_1_2_9_60_1 doi: 10.1016/j.biomaterials.2018.03.044 – ident: e_1_2_9_40_1 doi: 10.1016/j.addr.2017.05.010 – ident: e_1_2_9_41_1 doi: 10.1073/pnas.1820276116 – ident: e_1_2_9_2_1 doi: 10.1097/00007632-200112151-00002 – ident: e_1_2_9_3_1 doi: 10.1016/S0140-6736(02)07603-1 – ident: e_1_2_9_5_1 doi: 10.1016/j.tice.2016.05.008 – ident: e_1_2_9_25_1 doi: 10.1016/j.cellimm.2020.104047 – ident: e_1_2_9_56_1 doi: 10.1186/s12974-018-1193-6 – ident: e_1_2_9_28_1 doi: 10.1089/wound.2017.0775 – ident: e_1_2_9_35_1 doi: 10.1016/j.jconrel.2009.05.025 – ident: e_1_2_9_63_1 doi: 10.1021/acsami.8b05293 – ident: e_1_2_9_65_1 doi: 10.1089/neu.2006.23.635 – ident: e_1_2_9_49_1 doi: 10.1016/j.actbio.2019.11.012 – ident: e_1_2_9_59_1 doi: 10.1111/j.1471-4159.2011.07257.x – ident: e_1_2_9_6_1 doi: 10.1038/nrneurol.2010.73 – volume: 21 year: 2020 ident: e_1_2_9_17_1 publication-title: Int. J. Mol. Sci. – ident: e_1_2_9_44_1 doi: 10.1088/1741-2560/8/4/046033 – ident: e_1_2_9_55_1 doi: 10.3389/fcell.2021.570451 – ident: e_1_2_9_27_1 doi: 10.1155/2015/948040 – ident: e_1_2_9_34_1 doi: 10.1089/ten.tea.2007.0349 – ident: e_1_2_9_23_1 doi: 10.1016/j.biomaterials.2012.03.022 – ident: e_1_2_9_9_1 doi: 10.1093/brain/awy128 – ident: e_1_2_9_38_1 doi: 10.3171/spi.2001.95.2.0221 – ident: e_1_2_9_15_1 doi: 10.2478/s11658-013-0101-4 – ident: e_1_2_9_12_1 doi: 10.1016/j.biomaterials.2017.06.019 – ident: e_1_2_9_47_1 doi: 10.1007/s10571-015-0182-x – ident: e_1_2_9_16_1 doi: 10.1177/0363546519848678 – ident: e_1_2_9_57_1 doi: 10.1007/s13311-013-0254-x – ident: e_1_2_9_64_1 doi: 10.1088/1741-2552/aaa55c – ident: e_1_2_9_52_1 doi: 10.1158/1078-0432.CCR-09-1015 – ident: e_1_2_9_51_1 doi: 10.1016/S0955-0674(00)00199-X – ident: e_1_2_9_61_1 doi: 10.1097/PRS.0b013e31829fe1b0 – ident: e_1_2_9_48_1 doi: 10.3389/fimmu.2020.02135 – ident: e_1_2_9_18_1 doi: 10.1016/j.pneurobio.2010.11.002 – ident: e_1_2_9_36_1 doi: 10.1002/adma.201501558 – ident: e_1_2_9_4_1 doi: 10.1016/S1474-4422(18)30415-0 – ident: e_1_2_9_11_1 doi: 10.1038/srep34842 – ident: e_1_2_9_24_1 doi: 10.1172/jci.insight.131355 – ident: e_1_2_9_66_1 doi: 10.1039/C7BM00485K – ident: e_1_2_9_20_1 doi: 10.1021/cn200030w – ident: e_1_2_9_50_1 doi: 10.4049/jimmunol.180.6.4235 – ident: e_1_2_9_42_1 doi: 10.1016/j.pneurobio.2015.09.003 – ident: e_1_2_9_8_1 doi: 10.1152/physrev.00017.2017 – ident: e_1_2_9_22_1 doi: 10.1016/j.brainresbull.2019.03.005 – ident: e_1_2_9_30_1 doi: 10.1186/s13287-016-0356-6 – ident: e_1_2_9_54_1 doi: 10.1186/s12974-020-1726-7 – ident: e_1_2_9_46_1 doi: 10.1016/j.brainres.2014.12.045 – ident: e_1_2_9_58_1 doi: 10.1016/j.pharmthera.2013.01.004 – ident: e_1_2_9_39_1 doi: 10.1038/nature04478 – ident: e_1_2_9_13_1 doi: 10.1089/ten.teb.2011.0488 – ident: e_1_2_9_10_1 doi: 10.1016/j.biopha.2017.04.126 – ident: e_1_2_9_19_1 doi: 10.1016/j.jconrel.2015.08.060 – ident: e_1_2_9_31_1 doi: 10.1111/cns.13187 – volume: 21 year: 2020 ident: e_1_2_9_7_1 publication-title: Int. J. Mol. Sci. – ident: e_1_2_9_33_1 doi: 10.3390/cells9092113 – ident: e_1_2_9_37_1 doi: 10.1016/S0079-6123(06)61027-3 |
| SSID | ssj0031247 |
| Score | 2.5956259 |
| Snippet | Treatment for spinal cord injuries (SCIs) is often ineffective because SCIs result in a loss of nerve tissue, glial scar formation, local ischemia and... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e2107838 |
| SubjectTerms | Animals Biocompatibility Biological activity Biomedical materials Cell Extracts Cytokines Cytokines - metabolism fat extract Genotype & phenotype Humans Hyaluronic acid Hyaluronic Acid - pharmacology Hydrogels Inflammation - drug therapy Inflammation - metabolism Injury prevention M2 polarization Macrophages Mice Microglia Nanotechnology Polarization Spinal cord Spinal cord injuries Spinal Cord Injuries - drug therapy STAT6 |
| Title | Cell‐Free Extracts from Human Fat Tissue with a Hyaluronan‐Based Hydrogel Attenuate Inflammation in a Spinal Cord Injury Model through M2 Microglia/Microphage Polarization |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsmll.202107838 https://www.ncbi.nlm.nih.gov/pubmed/35333441 https://www.proquest.com/docview/2655421100 https://www.proquest.com/docview/2644010973 |
| Volume | 18 |
| WOSCitedRecordID | wos000772904400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1613-6829 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0031247 issn: 1613-6810 databaseCode: DRFUL dateStart: 20050101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELbolgM98E8JlMpISJyide38OEdYGhVpt6poK-0tsmO7LArZVZJFcOMReBPeiSdhJsmGrhBCglsS24mlmfF8Y2e-IeSFi1nOwlD7kVbMD-xR4idxHvqRY8zKKBGWubbYRHx6Kufz5OxaFn_HDzFsuKFltOs1GrjS9fgXaWj9scCjAwhZYinkDtnloLzBiOy-eZdeTjersQD_1RZYAbflI_fWhriR8fH2G7Yd029ocxu8tt4nvfP_875LbvfIk77qVOUeuWHL-2TvGh_hA_J9Yovix9dvaWUtPf7cYAZVTTEDhbab_TRVDb1oRUVxA5cqevJFFesK4HwJ416DSzTwyFTLKwufagCQrwHM0relA83rsiTpooRx5yssx0UnEPtC6weQLMWybAXtCwfRGacz_FnwqliocXu1eg9rHz3DWLxPHn1ILtPji8mJ31d08HNkUPK50RbkwaVmeQiaEED0ExoVmkBZrkVguQOI6WLHEi2SUBpzpJmRLuegUZwZ8YiMymVpHxOa61BHEbMQryWBDBwenzIZa-WEVEYlHvE34szynu4cq24UWUfUzDMURDYIwiMvh_6rjujjjz0PNtqR9QZfZzwCXIbBNPPI86EZTBXPX1Rpl2vsEwR4EhkLj-x3WjV8SgDsFgBNPcJb5fnLHLLz2XQ63D35l0FPyS2OqRztX0gHZNRUa_uM3Mw_NYu6OiQ78Vwe9sb0E_HbIfk |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtMwELagiwQc-F0gsICRkDhF9dr5cY5QNuqKtFqxXWlvkR3bS1FIq7RFcOMReBPeiSdhJkkDFUJIiFt-7DjSzHi-sT3fEPLcxaxgYaj9SCvmB_Yw8ZO4CP3IMWZllAjLXFNsIp5O5fl5ctKdJsRcmJYfol9wQ8to5ms0cFyQHv5kDV19KHHvAGKWWAp5mewFoEvhgOy9fpueZdvpWIADayqsgN_ykXxry9zI-HD3C7ue6Te4uYteG_eT3vwPP36L3OiwJ33ZKsttcslWd8j1XxgJ75JvI1uW3798TWtr6dGnNeZQrSjmoNBmuZ-mak1njbAoLuFSRcefVbmpAdBX0O8VOEUDj0y9uLAw1Bog-QbgLD2uHOhemydJ5xX0O11iQS46gugX3r4H2VIszFbSrnQQnXA6weOCF-VcDZur5TuY_egJRuNd-ug-OUuPZqOx39V08AvkUPK50RYEwqVmRQi6EED8ExoVmkBZrkVguQOQ6WLHEi2SUBpzqJmRruCgU5wZcY8MqkVlHxBa6FBHEbMQsSWBDBxuoDIZa-WEVEYlHvG38syLjvAc626UeUvVzHMURN4LwiMv-vbLlurjjy0PtuqRdya_ynkEyAzDaeaRZ_1rMFbcgVGVXWywTRDgXmQsPHK_Vat-KAHAWwA49QhvtOcv_5CfTrKsv3v4L52ekqvj2STLs-Ppm0fkGsfEjuZM0gEZrOuNfUyuFB_X81X9pLOpH21HJQE |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagRQgO_BcCBYyExCla186Pc4Rto1bsrla0lXqL7NguW4XsKptFcOMReJO-U5-EmSQbWCGEhLjlx44jzYznG9vzDSGvXcxyFobaj7RifmD3Ej-J89CPHGNWRomwzDXFJuLJRJ6dJdPuNCHmwrT8EP2CG1pGM1-jgduFcYOfrKHLTwXuHUDMEkshr5PtIEwisM3t_Q_p6Wg9HQtwYE2FFfBbPpJvrZkbGR9sfmHTM_0GNzfRa-N-0rv_4cfvkTsd9qRvW2W5T67Z8gG5_Qsj4UNyObRFcfXte1pZSw--1JhDtaSYg0Kb5X6aqpqeNMKiuIRLFT38qopVBYC-hH7vwCkaeGSq-bmFoWqA5CuAs_SodKB7bZ4knZXQ73iBBbnoEKJfeHsBsqVYmK2gXekgOuZ0jMcFz4uZGjRXi48w-9EpRuNd-ugjcpoenAwP_a6mg58jh5LPjbYgEC41y0PQhQDin9Co0ATKci0Cyx2ATBc7lmiRhNKYPc2MdDkHneLMiB2yVc5L-4TQXIc6ipiFiC0JZOBwA5XJWCsnpDIq8Yi_lmeWd4TnWHejyFqqZp6hILJeEB5507dftFQff2y5u1aPrDP5ZcYjQGYYTjOPvOpfg7HiDowq7XyFbYIA9yJj4ZHHrVr1QwkA3gLAqUd4oz1_-YfseDwa9XdP_6XTS3Jzup9mo6PJ-2fkFse8juZI0i7ZqquVfU5u5J_r2bJ60ZnUD8JOJHw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cell%E2%80%90Free+Extracts+from+Human+Fat+Tissue+with+a+Hyaluronan%E2%80%90Based+Hydrogel+Attenuate+Inflammation+in+a+Spinal+Cord+Injury+Model+through+M2+Microglia%2FMicrophage+Polarization&rft.jtitle=Small+%28Weinheim+an+der+Bergstrasse%2C+Germany%29&rft.au=Xu%2C+Guang%E2%80%90Yu&rft.au=Xu%2C+Shun&rft.au=Zhang%2C+Yu%E2%80%90Xuan&rft.au=Yu%2C+Zi%E2%80%90You&rft.date=2022-04-01&rft.issn=1613-6810&rft.eissn=1613-6829&rft.volume=18&rft.issue=17&rft_id=info:doi/10.1002%2Fsmll.202107838&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_smll_202107838 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1613-6810&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1613-6810&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1613-6810&client=summon |